Lupin planning to set up pharmaceutical manufacturing plant in Florida

09 Oct 2025 Evaluate

Lupin is planning to set up a new state-of-the-art pharmaceutical manufacturing plant in Coral Springs, Florida. With a projected cumulative investment of $250 million, including research & development, infrastructure and capital expenditures over a five-year period, the new site will have the capacity to accommodate the production of more than 25 critical respiratory medicines, including lifesaving albuterol inhalers for children with asthma and service members at home and overseas.

By strengthening domestic manufacturing and enhancing supply chain diversification, this critical project will enhance medicine security and strengthen company’s position as a global respiratory leader. Locally, this will generate over 200 new long-term, skilled jobs by 2030 in Broward County. The Coral Springs facility will anchor U.S. production of critical respiratory therapies, diversify the supply chain, and ensure affordable, reliable access - from routine pediatric care to pandemic-scale demand. The company has acquired more than 5 acres of land to embark on this expansion of 70,000 square feet.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2102.50 10.55 (0.50%)
05-Dec-2025 15:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.00
Dr. Reddys Lab 1276.05
Cipla 1521.20
Zydus Lifesciences 931.85
Lupin 2102.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×